Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0000899243-17-008731

10% owner sold 1,650,000 shares at an average $17.39 ($28,700,395)

From the SEC's structured data for this filing

Trades in this filing

THIRD ROCK VENTURES LP · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-03-23 Sale : show line 1 in the form −1,000,000 $17.00 $17,000,200 5,820,348 D
2017-03-27 Sale : show line 2 in the form −650,000 $18.00 $11,700,195 5,170,348 D
Open-market sales · 1,650,000 sh · avg $17.39 · $28,700,395
Loading xslF345X03/doc4.xml…